Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-08-13

FDA Approved: SAPHRIS — Original Application (Allergan, Inc.)

View source ↗

Summary

The FDA approved SAPHRIS (asenapine maleate) from Allergan in an original application for the treatment of schizophrenia and for the acute treatment of manic or…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Saphris (asenapine)

Snippet

ORIG AP for SAPHRIS (ASENAPINE MALEATE)